Genmab — August 2016
-
What we know is that still from the first study, which is published in the New England Journal of Medicine last August, the very first DARZALEX study, they are still patients at the 60 milligrams per kilogram dose, still being dosed as we speak and benefiting from the drug, and those patients were essentially recruited in the 2012 timeframe. So from that, you can calculate the potential length of time that patients are on that yourself.
-
bare en detalje, det er vel 16mg/kg, som er den gældende dosering i dag
-
men absolut lovende for maintenace/smoldering
-
udlandet må efterhånden gerne stoppe udsalget
-
Sukkeralf - det lyder ikke på mig, som om David udelukker noget mht sales milestones. Jeg syntes det er sindssygt skarpt set af Novod (ikke at det nødvendigvis er rigtigt) - men en salesmilestone ville vel egentlig være naturlig at have med i pakken, når nu royaltysatsen kun er 12%
-
hvis der ligger en milestone på 500 mio usd i salg, så vil det forklare en del om uvilligheden til at opjustere lidt mere mærkbart
-
det lyder som en fornuftig trappe
-
David rystede lidt mere ud af ærmet end sædvanligt. Han sagde, at der kommer mere kød på future cost til kapitalmarkedsdagen 10 nov - og så tilføjede han den her "But I think I would -- at this early stage, would expect a cost increase for 2017."
-
Langt om længe kommer der turbo på klinikken
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind